Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0452
Source ID: NCT01157260
Associated Drug: Kremezin
Title: The Effects of AST-120 on Endothelial Dysfunction in Patients With Chronic Kidney Disease
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Kidney Failure, Chronic
Interventions: DRUG: Kremezin
Outcome Measures: Primary: Changes of FMD(Flow Mediated Dilatation), FMD (Flow Mediated Dilatation): percent change of FMD response to hyperemia and after sublingual nitroglycerin on brachial artery., 6 months | Secondary: Level of Indoxyl Sulfate, 3 months, 6 months
Sponsor/Collaborators: Sponsor: Ewha Womans University
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 30
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2010-09
Completion Date: 2011-12
Results First Posted:
Last Update Posted: 2010-07-07
Locations: Ewha Womans University Mokdong Hospital, Seoul, Korea, Republic of
URL: https://clinicaltrials.gov/show/NCT01157260